HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph Sodroski Selected Research

CD4 Antigens (CD4 Antigen)

11/2021Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.
1/2020Slow Receptor Binding of the Noncytopathic HIV-2UC1 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity.
1/2011Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening.
1/2008Adaptation of the human immunodeficiency virus type 1 envelope glycoproteins to new world monkey receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph Sodroski Research Topics

Disease

57Infections
11/2021 - 08/2002
11Virus Diseases (Viral Diseases)
12/2020 - 05/2002
4Retroviridae Infections (Infection, Retrovirus)
07/2013 - 10/2007
2COVID-19
04/2021 - 12/2020
2HIV Infections (HIV Infection)
01/2017 - 11/2011
2Acquired Immunodeficiency Syndrome (AIDS)
11/2011 - 01/2004
2Avian Sarcoma
08/2007 - 10/2005
1Superinfection
01/2020
1Reinfection
11/2019
1Hypersensitivity (Allergy)
01/2017
1Viremia
01/2014
1Human Influenza (Influenza)
02/2008
1AIDS Dementia Complex
11/2007
1Alzheimer Disease (Alzheimer's Disease)
09/2002
1Vesicular Stomatitis
09/2002
1Dementia (Dementias)
09/2002

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2002
20Glycoproteins (Glycoprotein)IBA
04/2021 - 08/2002
11AntibodiesIBA
01/2020 - 01/2003
7Neutralizing AntibodiesIBA
11/2021 - 01/2003
7VaccinesIBA
04/2021 - 12/2004
5Tripartite Motif ProteinsIBA
07/2013 - 12/2005
4CD4 Antigens (CD4 Antigen)IBA
11/2021 - 01/2008
4Antiviral Agents (Antivirals)IBA
01/2019 - 07/2006
3Cyclophilin AIBA
05/2014 - 08/2006
3recombinant soluble CD4IBA
01/2014 - 04/2009
3Peptides (Polypeptides)IBA
05/2008 - 09/2002
2LigandsIBA
01/2020 - 02/2004
2EpitopesIBA
02/2017 - 01/2003
2Anti-Infective Agents (Microbicides)IBA
06/2014 - 11/2011
2N- (4- chlorophenyl)- N'- (2,2,6,6- tetramethylpiperidin- 4- yl)oxalamideIBA
11/2008 - 09/2006
2Arginine (L-Arginine)FDA Link
10/2007 - 07/2006
2DNA (Deoxyribonucleic Acid)IBA
05/2004 - 01/2004
1COVID-19 VaccinesIBA
12/2020
1PF 68742IBA
11/2019
1Viral Envelope ProteinsIBA
01/2017
1Reducing AgentsIBA
01/2015
1gag Gene Products (gag Protein)IBA
05/2014
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
07/2013
1furanIBA
08/2012
1imidazoleIBA
08/2012
1AcidsIBA
08/2012
1Cardiolipins (Cardiolipin)IBA
11/2011
1Liposomes (Liposome)IBA
11/2011
1LipidsIBA
11/2011
1UbiquitinIBA
08/2011
1Ligases (Synthetase)IBA
08/2011
1leptomycin BIBA
05/2011
1mRNA Cleavage and Polyadenylation FactorsIBA
03/2010
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2009
1Codon (Codons)IBA
08/2009
1Influenza Vaccines (Influenza Vaccine)FDA Link
02/2008
1ChemokinesIBA
11/2007
1Human immunodeficiency virus 1 gp140 envelope proteinIBA
11/2007
1Capsid Proteins (Capsid Protein)IBA
08/2006
1geldanamycinIBA
12/2005
1IntegrasesIBA
01/2004
1Amyloid (Amyloid Fibrils)IBA
09/2002
1Amyloid beta-PeptidesIBA
09/2002
1AIDS VaccinesIBA
05/2002

Therapy/Procedure

2Therapeutics
01/2020 - 11/2011